Perseverance Pays

April 4, 2008 @ 3:28 am · Filed under Cleveland BioLabs, Contract Awards, Department of Defense, development program

Cleveland Biolabs who at the beginning of the year failed to win a large contract from DoD for a drug to treat radiation poisoning was rewarded yesterday with another contract. See the article here. A previous post on the matter can be found here. This contract worth about $9 M pales compared to the one awarded previously at $225 M but will help the company move forward with its research.   Read the rest of this entry »

Tagged with: , , , , , ,

Osiris defense contract makes company take off

January 12, 2008 @ 6:25 am · Filed under Cleveland BioLabs, Contract Awards, Osiris Therapuetics, development program

As previously discussed, the contract Osriris won from DoD for a drug to treat radiation damage to the gastrointestinal system has really caused the company and its stock to take off. See previous posts here and here for more detail. The contract could be worth $225 M initially, and if the US Government decides to use it for civilian use the value could be unlimited. See CNNMoney.com for more.

Cleveland BioLabs Loses Out to Osiris For Radiation Treatment Contract

January 4, 2008 @ 10:38 pm · Filed under Cleveland BioLabs, Contract Awards, Department of Defense, Osiris Therapuetics, medicine

As we reported earlier today, Osiris Therapeutics won a Department of Defense contract to develop a treatment for radiation sickness. Unfortunately, Osiris’s gain was Cleveland BioLabs’ loss. Cleveland’s “shares plummeted nearly 60% after the Buffalo, N.Y., company’s proposed treatment for the gastrointestinal effects of radiation sickness, Protectan CBLB502, wasn’t chosen.” More details at The Street.

Tagged with: , ,